Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Cancer. 2017 Sep 1;123(17):3320-3325. doi: 10.1002/cncr.30746. Epub 2017 Apr 25.
The highest rates of thyroid cancer are observed in Pacific Island nations as well as Australia and Asian countries bordering the Pacific. The objective of this study was to determine the risk for thyroid cancer among immigrants to Canada from Southeast and East Asia compared with immigrants from other regions and nonimmigrants.
This was a population-based, longitudinal cohort study using health care administrative data to examine all residents of Ontario without pre-existing thyroid cancer. Individuals were followed from January 1997 or 5 years after they became eligible for health care coverage in Ontario, whichever came later. Patients were followed until March 2015 for incident-differentiated thyroid cancer, and then for recurrence.
The study followed 14,659,733 individuals for a median of 17 years. Thyroid cancer incidence was 43.8 cases per 100,000 person-years among Southeast Asian immigrants, 28.6 cases per 100,000 person-years among East Asian immigrants, 21.5 cases per 100,000 person-years among other immigrants, and 14.5 cases per 100,000 person-years among nonimmigrants. Incidence was highest among immigrants from the Philippines (52.7 cases per 100,000 person-years), South Korea (33.5 cases per 100,000 person-years), and China (30.0 cases per 100,000 person-years). Adjusted hazard ratios for thyroid cancer compared with nonimmigrants were 2.66 (95% confidence interval, 2.48-2.84) for Southeast Asian immigrants, 1.87 (95% confidence interval, 1.75-2.00) for East Asian immigrants, and 1.51 (95% confidence interval, 1.45-1.57) for other immigrants. Immigrants were more likely to have papillary histology and stage I cancer. East Asian immigrants, but not Southeast Asian immigrants, had a lower risk of recurrence (hazard ratio, 0.73 [95% confidence interval, 0.57-0.94] and 1.01 [95% confidence interval, 0.81-1.26], respectively).
Immigrants from Southeast and East Asia had markedly higher thyroid cancer incidence than nonimmigrants. At particularly elevated risk were immigrants from the Philippines, South Korea, and China. Cancer 2017;123:3320-5. © 2017 American Cancer Society.
甲状腺癌发病率最高的国家为太平洋岛国、澳大利亚以及亚洲太平洋沿岸国家。本研究旨在评估与来自其他地区的移民和非移民相比,东南亚和东亚移民移居加拿大后罹患甲状腺癌的风险。
这是一项基于人群的纵向队列研究,通过医疗保健管理数据来评估安大略省所有无甲状腺癌既往史的居民。1997 年 1 月或在安大略省有资格获得医疗保健后 5 年(以较晚者为准)起,对个体进行随访。患者随访至 2015 年 3 月以发现分化型甲状腺癌,并进行复发随访。
本研究共随访了 14659733 名个体,中位随访时间为 17 年。东南亚移民的甲状腺癌发病率为 43.8/10 万患者年,东亚移民为 28.6/10 万患者年,其他移民为 21.5/10 万患者年,非移民为 14.5/10 万患者年。发病率最高的是来自菲律宾(52.7/10 万患者年)、韩国(33.5/10 万患者年)和中国(30.0/10 万患者年)的移民。与非移民相比,东南亚移民的甲状腺癌调整后风险比为 2.66(95%置信区间,2.48-2.84),东亚移民为 1.87(95%置信区间,1.75-2.00),其他移民为 1.51(95%置信区间,1.45-1.57)。移民更可能具有乳头状组织学和 I 期癌症。东亚移民而非东南亚移民的复发风险较低(风险比,0.73[95%置信区间,0.57-0.94]和 1.01[95%置信区间,0.81-1.26])。
东南亚和东亚移民的甲状腺癌发病率明显高于非移民。来自菲律宾、韩国和中国的移民风险尤其高。癌症 2017;123:3320-5。©2017 美国癌症协会。